Hyundai Bioscience Co., Ltd. (048410.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 476.84B |
| Enterprise Value | 472.32B |
| P/E Ratio | -25.59 |
| PEG Ratio | 1.35 |
| Price/Sales Ratio | 204.88 |
| Price/Book Ratio | 6.56 |
| Enterprise/Revenue | 206.6 |
| Enterprise/EBITDA | -38.45 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -7.97 |
| Operating Margin | -5.8 |
AD
Management Effectiveness
| Return On Assets | -0.2 |
| Return On Equity | -0.24 |
Income Statement
| Revenue | 3.52B |
| Revenue/Share | 34.54 |
| Gross Profit | -1.03B |
| EBITDA | -16.86B |
| Net Income | -22.13B |
| Diluted EPS | -230.41 |
Balance Sheet
| Total Cash | 41.84B |
| Total Cash/Share | 435.14 |
| Total Debt | 22.79B |
| Total Debt/Equity | 0.22 |
| Current Ratio | 2.36 |
| Book Value Per Share | 1,074.17 |
Price History
| 52-Week Change | 34.29 |
| 52-Week High | 21,500 |
| 52-Week Low | 4,565 |
| Moving Average 50 Days | 6,679 |
| Moving Average 200 Days | 9,638.08 |
Statistics
| Average Volume | 1.1M |
| Shares Outstanding | 96.5M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | July 24, 2025 |
AD
